Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Jalra
(vildagliptin)
Uses, side effects, dosage information & price range
About this medicine
Vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus: as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4.4, 4.5 and 5.1 for available data on different combinations).
Common Brand Names for this Composition
The following popular commercial brand names contain vildagliptin as their active ingredient composition:
Jalra-M 50mg/500mg Tablet
USV Ltd
Galvus 50mg Tablet
Novartis India Ltd
Jalra
Novartis Europharm Limited
Xiliarx
Novartis Europharm Limited
Eucreas
Novartis Europharm Limited
Icandra (previously Vildagliptin / metformin hydrochloride Novartis)
Novartis Europharm Limited
Zomarist
Novartis Europharm Limited
Vildagliptin / Metformin hydrochloride Accord
Accord Healthcare S.L.U.
Galvus
Novartis Europharm Limited
Common Substitutes & Alternatives
These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.
Key Information
Salt / Composition
vildagliptin
Category
Dipeptidyl peptidase 4 (DPP-4) inhibitors;Drugs used in diabetes
Manufacturer
Novartis Europharm Limited
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.